CLINICAL_TRIALS
other
· 2014-02-07
Clinical Trial Update: Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. [Phase 2]
Summary
An update on a Phase 2 trial evaluating JVS-100 for ischemic heart failure; no trial results are provided in the update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Juventas Therapeutics, Inc. | Conditions: Ischemic Heart Failure | Phase 2 | Status: UNKNOWN